A Case of Organizing Pneumonia Associated with FOLFIRI Chemotherapy / 결핵및호흡기질환
Yoon-Jeong LEE; Jun-Hyun KIM; Sun-Woong KIM; Won-Chan KANG; Soo-Jung KIM; Ji-Hye KIM; Sun-Jong KIM.
Tuberculosis and Respiratory Diseases
; : 262-265, 2014.
Artículo
en Inglés
| WPRIM | ID: wpr-159753
The combination chemotherapy of irinotecan with 5-fluorouracil and leucovorin (FOLFIRI regimen) was recently proven to be beneficial in patients with advanced colorectal cancer. Pulmonary toxicity is very rare in adverse effects of irinotecan. No case of organizing pneumonia (also known as bronchiolitis obliterans organizing pneumonia) associated with FOLFIRI chemotherapy has been reported. We experienced a case of a 62-year-old man who presented persistent dry cough and progressive dyspnea after receiving chemotherapy with FOLFIRI regimen. After surgical lung biopsy, the patient was diagnosed with FOLFIRI chemotherapy-induced organizing pneumonia which was successfully treated with steroid therapy.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados